Bio-Rad Laboratories PE ratio BIO

Share price divided by earnings per share over the last twelve months, since 2011.

Today, Oct 23, 2026: 44.8×
10-year median: 30.8×
Against its 10-year history: 56th; percentile: 0 is its lowest day, 100 its highest
10-year range: 5.3× to 457×
Peer median: 35.9×

Bio-Rad Laboratories' PE ratio is 44.8× as of Oct 23, 2026: a share price of $369.95 against $8.25 of earnings per share over the last twelve months.

That is above its ten-year median of 30.8×, close to the middle of its last ten years.

Over that time it ranged from 5.3× in Dec 2018 to 457× in Sep 2017.

The median for 10 diagnostics and research stocks of a similar size is 35.9×.

PE ratio over time

median 30.8×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	44.8×	10.0×	53.6×
2025	28.9×	22.5×	28.9×
2024	n/m a value too high to mean anything
2023	n/m a value too high to mean anything
2022	n/m a value too high to mean anything
2021	n/m a value too high to mean anything
2020	10.1×	10.1×	33.1×
2019	30.2×	5.4×	30.7×
2018	5.4×	5.3×	347×
2017	302×	56.0×	457×
2016	54.7×	34.3×	55.1×
2015	39.5×	38.5×	46.2×
2014	44.0×	39.4×	57.4×
2013	40.2×	17.1×	40.2×
2012	16.4×	14.8×	17.9×
2011	14.6×	13.7×	19.1×

Against its peers

Companies in Medical - Diagnostics & Research nearest Bio-Rad Laboratories' size, closest first, today.

Company	PE ratio
BIOBio-Rad Laboratories	44.8×
CAICaris Life Sciences	86.5×
LNTHLantheus	24.2×
RVTYRevvity	75.6×
MEDPMedpace	39.2×
BLLNBillionToOne	166×
VCYTVeracyte	34.2×
LHLabcorp	27.2×
DGXQuest Diagnostics	25.7×
CDNACareDx	33.4×
MTDMettler-Toledo International	37.6×
Peer median	35.9×

Where Bio-Rad Laboratories ranks

#13of 20Diagnostics and research stocks with the lowest PE ratio

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Bio-Rad Laboratories

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.